Longevity Health Surges 60% After Hours On Merger With THPlasma
Longevity Health Holdings Inc. (NASDAQ:XAGE) stock price surged by 59.92% in the after-hours trading session on Monday.
Check out how Longevity Health Holdings stock is standing here.
What Happened: The stock price of Longevity Health Holdings saw an increase in the after-hours trading session, reaching $4.23.
Earlier on Monday, Longevity Health Holdings Inc. announced a merger with THPlasma and the termination of its transaction with 20/20 BioLabs. This strategic move is expected to leverage plasma synergies to drive bioaesthetic innovation.
See Also: Fashion To Flower: How A Streetwear Brand Conquered Cannabis – Benzinga
George Chi, the CEO of the bio-aesthetic company- Longevity Health Holdings Inc. stated, "I am thrilled to announce our merger with Longevity, a transformative step expected to supercharge our growth by unlocking access to public markets and future M&A opportunities. Our teams are strategically aligned to fuel innovation, accelerate scale, and deliver value across the board. This is an exciting milestone in our journey, and I look forward to the incredible opportunities ahead as we build the future together through our disciplined execution approach."
Why It Matters: This surge in stock price comes after a series of strategic moves by Longevity Health Holdings. The company had earlier executed a definitive merger agreement with True Health and extended its strategic partnership with Humana (NYSE:HUM) through 2030.
These strategic moves have been well received by the market, with the stock price of XAGE seeing a significant increase in the after-hours trading session, indicating investor confidence in the company’s future prospects.
Price in Action: XAGE closed at a price of $2.65, experiencing 1.31% drop. In after-hours trading, the stock price rose to $4.23, according to Benzinga Pro data.
Benzinga's Edge Stock Rankings indicates Longevity Health stock has a negative trend across all time frames. Find out the stock value of other bio-aesthetic brands.
Read Next:
Photo Courtesy: Jacktamrong on Shutterstock.com
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Gorodenkoff via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Equities M&A News Health Care Commodities Events Market-Moving Exclusives After-Hours Center